Related Experiment Video
Updated: Mar 10, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Quality of Life of Cypriot Patients Suffering with Huntington's Disease
Eleni Varda1, Christiana A Demetriou2, Alexandros Heraclides3
1The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Insights
Quality of life in Huntington
Area of Science:
- Neurology
- Quality of Life Research
- Genetic Disorders
Background:
- Huntington's disease (HD) presents significant motor, behavioral, and cognitive challenges, profoundly impacting patient and family quality of life (QoL).
- Limited research exists on QoL for HD patients, particularly in Cyprus, necessitating further investigation to understand living conditions and improve management.
- This study addresses the need for assessing QoL among Cypriot HD patients due to the disease's severity and prevalence.
Purpose of the Study:
- To evaluate the health-related quality of life (QoL) in patients diagnosed with Huntington's disease (HD) residing in Cyprus.
- To identify specific domains of QoL most affected by Huntington's disease in the Cypriot patient population.
- To explore potential determinants, such as age at onset and disease duration, influencing QoL in this cohort.
Main Methods:
- A cross-sectional study design was employed to assess QoL.
- The standardized EQ-5D health-related QoL questionnaire was administered to 34 Huntington's disease patients in Cyprus.
- This sample represented 46% of the total known HD patient population in Cyprus.
Main Results:
- Self-care and performance of usual activities were the most severely impacted QoL domains (37.5% and 40.6% reporting severe problems, respectively).
- Mobility and psychosocial well-being were also significantly affected, with 25.0% and 15.6% reporting severe problems, respectively.
- Age at onset and disease duration were identified as significant determinants impacting mobility, self-care, and usual activities, as well as the overall QoL score.
Conclusions:
- Age at onset and disease duration critically influence the QoL of Cypriot Huntington's disease patients, particularly affecting mobility and daily functioning.
- A notable percentage of patients reported 'Some Problems' in the Pain/Discomfort category, possibly due to questionnaire translation issues, highlighting the need for culturally adapted instruments.
- The significant psychosocial burden, even on asymptomatic patients, requires targeted acknowledgment and management strategies to enhance overall QoL.
Introduction:
Huntington's disease (HD) has profound motor, behavioural and cognitive symptoms. Despite the enormous burden of this disease on the quality of life (QoL) of patients and their families, there is very limited evidence on this topic. Considering the severity of HD patients, and the high prevalence in Cyprus more studies are needed to assess QoL among Cypriot patients, in order to improve our knowledge about their living conditions and to assist the management of this condition. Project Aim: The aim of this cross-sectional study is to assess QoL among Cypriot patients with HD, using a standardized health-related QoL questionnaire.
Materials And Methods:
A generic QoL questionnaire was used, namely EQ-5D, which is a standardised instrument for use as a measure of health outcomes and is applicable to a wide range of health conditions. The study was conducted with 34 patients, which represented 46% of the Cypriot HD patient population.
Results:
Ability of patients to care for themselves and to carry out usual activities were reported to be most severely affected (37.5% and 40.6% replying "Severe Problems" respectively). Mobility and psychosocial well-being were also affected to a lesser extent (25.0% and 15.6% replying "Severe Problems"). Interestingly, in the anxiety/depression scale, 77.8% of asymptomatic patients reported "Some Problems". Half of the patients did not experience pain or discomfort but 40.6% reported "Some Problems" and 6.3% reported "Severe Problems". The Health Status as perceived by the patients was found to be moderately to severely affected. In multivariate ordinal regression analyses, age at onset and disease duration significantly impacted on self-care. In addition, disease duration was significantly associated with mobility, self-care and usual activities scales. No significant determinants were evidenced for Pain/Discomfort and Anxiety/Depression. Lastly, age of onset was found to be the only significant determinant of the cumulative QoL score (Range=5-15).
Conclusions:
Age at onset and disease duration were found to severely affect the QoL of Cypriot HD patients, and more specifically their mobility, ability to self-care and perform usual activities. The percentage of patients reporting "Some Problems" in the Pain/Discomfort category can be explained by the direct translation of the word as presented in the questionnaire, indicating the need for language specific instruments. Perhaps more noteworthy is the phychosocial burden on even asymptomatic patients, which needs to be acknowledged and managed to improve their quality of life.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test